Malignant fibrous histiocytoma: Difference between revisions
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 18: | Line 18: | ||
==[[Malignant fibrous histiocytoma epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Malignant fibrous histiocytoma epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Malignant fibrous histiocytoma | ==[[Malignant fibrous histiocytoma risk factors|Risk Factors]]== | ||
==[[Malignant fibrous histiocytoma natural history|Natural History, Complications and Prognosis]]== | ==[[Malignant fibrous histiocytoma natural history|Natural History, Complications and Prognosis]]== |
Revision as of 15:21, 18 December 2015
For patient information, click here
Malignant fibrous histiocytoma Microchapters |
Differentiating Malignant Fibrous Histiocytoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Malignant fibrous histiocytoma On the Web |
American Roentgen Ray Society Images of Malignant fibrous histiocytoma |
Directions to Hospitals Treating Malignant fibrous histiocytoma |
Risk calculators and risk factors for Malignant fibrous histiocytoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Malignant Fibrous Histiocytoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
de:Malignes Fibröses Histiozytom} Template:WH Template:WikiDoc Sources